top of page

Operationalizing the Dupont Formula and More - Part 1

  • Writer: greenwoodphilip
    greenwoodphilip
  • Jun 20, 2024
  • 4 min read

Financial ratios like ROI, ROA, and ROE are crucial performance measures used globally by companies. The tech industry has introduced a variety of financial and non-financial metrics, such as MAU (Monthly Average Users) and ARR (Annual Recurring Revenue), commonly used by startups seeking funding. Determining the optimal ratio is complex and depends on factors like company maturity, industry, and strategic priorities. After forty years of teaching at the Wisconsin School of Business, this post will expand on the profitability ratio taught in our Entrepreneurial Management course that, like the DuPont formula, provides a systematic way to identify the drivers of profitability and overcomes some of the weaknesses of historical ratios like Return on Equity/DuPont Formula.



The DuPont formula is a widely used financial ratio that dissects Return on Equity (ROE) into net profit margin, asset turnover, and equity multiplier. This analysis provides insight into a company's financial health and profitability factors.


The DuPont Formula:


Return on Equity = Net Earnings/Total Equity

Return on Equity = (Net Earnings/Total Assets) x (Total Assets/Total Equity)

Return On Assets x Leverage

Return on Equity = (Net Earnings/Sales) x (Sales/Total Assets) x (Total Assets/Total Equity)

Return on Sales x Asset Turnover x Leverage


The DuPont Formula, originating in the 1910s, breaks down factors influencing Return on Equity, offering:

  • In-depth Understanding - enabling analysts to grasp specific drivers behind profitability, providing insights on operational efficiency, asset utilization, and financial leverage.

  • Highlighting Areas for Enhancement - isolating components to pinpoint areas for performance improvement, such as inefficient asset utilization or cost management issues.

  • Facilitating Comparative Analysis - simplifying comparisons between companies or industry standards.

  • Supporting Strategic Financial Planning - guiding decision-making, setting financial objectives, optimizing capital structure, and enhancing financial performance.


The DuPont Formula, like other financial ratios, has its limitations due to its reliance on accounting data and historical context. It offers a restricted evaluation of financial health and may vary between industries. When analyzing Return on Equity (ROE), two crucial factors need to be considered. Firstly, the numerator (Net Earnings) excludes interest and tax payments, enabling companies to manipulate their ROE through financial decisions such as favoring debt over equity and utilizing tax strategies, potentially distorting the true profitability from core operations. Secondly, the denominator solely focuses on Equity while disregarding debt, allowing numerous companies to enhance their ROE by minimizing equity financing.


One way to address some of these issues with ROE and the DuPont Formula is to view them using different variables in the ROE equation that enable users of the information to see the drivers of change in profitability from a different viewpoint. One alternative is:


ROE = (1-T) x (ROAI + (Leverage*(ROAI - Cost of Debt)) where


  • T = Effective Tax Rate of the firm, Tax Expense/Earnings Before Taxes

  • ROAI = Earnings Before Interest Expense and Tax Expense (EBIT) / Asset Investment (AI). Recall, Asset Investment = Equity + Interest Bearing Debt

  • Leverage (L) = Interest Bearing Debt/Equity, and

  • Cost of Debt = Interest Expense/Interest Bearing Debt , this ratio estimates the interest rate paid on the firm's debt over the time period under study.


ROAI (has been discussed in a previous post) represents a more powerful profitability indicator because of its inclusion of EBIT in the numerator and all financing capital (debt and equity) in the denominator. But, what about the 'Cost of Debt'? The rationale for using Cost of Debt instead of a Weighted Average Cost of Capital as a benchmark hurdle rate is that we first want to determine if operating profits are making enough to cover the interest paid on the debt.


Example

The Dry Bean Company, a Midwest coffee house chain, will be analyzed as a case study for financial ratios. Despite its size, the company shows strong financial performance. The Return on Equity decreased from 156.4% in 2020 to 59.4% in 2022 due to substantial equity growth. The company retained a high percentage of net earnings. (Financials and ratios provided below)


IIn the years 2020-2022, the company witnessed a decrease in ROAI and spread due to a strategic reduction in leverage, achieved by retaining profits to bolster equity. Dry Bean maintains a strong ROE, with a significant indicator being the spread (meeting the +2% guideline). A spread falling below +2% or turning negative can indicate potential debt challenges, potentially leading to a "Debt Spiral" and the risk of bankruptcy. In 2022, Dry Bean further decreased its leverage. While it is prudent to steer clear of excessive debt, utilizing interest-bearing debt could enhance ROE in conjunction with equity. Shareholders may push for increased debt financing to yield higher returns on new ventures with lower capital costs compared to ROAI.


Conclusion


Return on Equity (ROE) is a key financial metric revealing a company's profitability and efficiency. Understanding ROE involves analyzing various factors influencing its fluctuations. Examining ROE from different angles uncovers trends and key drivers impacting financial performance.


For instance, analyzing Dry Bean's ROE can provide insights into its operations and financial health by dissecting components like net income and shareholder equity. Future articles will delve into Dry Bean's ROE results for a comprehensive analysis, aiming to identify challenges and optimize financial outcomes.


In future posts, we'll examine aligning the big number (e.g., ROE) with operations by deconstructing the formula.



2020

2021

2022

ROAI (a)

117.8%

75.5%

79.6%

Cost of Debt (b)

18.7%

17.0%

16.2%

Spread (c=a-b)

99.1%

58.5%

63.4%

Leverage (d)

1.17

0.79

0.31

1-Tax Rt (e)

67.0%

59.9%

59.9%

  ROE (a+(c x d))*e

156.4%

73.0%

59.4%



Return on Equity =



2020

2021

2022

Net Income


122

130

202

Equity


78

178

340

ROE


156.4%

73.0%

59.4%


Return on Assets Invested



2020

2021

2022

EBIT


199

241

354

Assets Inv





  Equity


78

178

340

  Int BearDebt


91

141

105

Assets Invested


169

319

445

ROAI


118%

76%

80%

Cost of Debt




2020

2021

2022

Int Expense


17

24

17

IBD


91

141

105

  Cost of Debt


18.7%

17.0%

16.2%

Spread = ROAI - Cost of Debt



2020

2021

2022

Spread


99.1%

58.5%

63.4%

Leverage



2020

2021

2022

IBD


91

141

105

Equity


78

178

340

Leverage


1.17

0.79

0.31



Effective Tax Rate



2020

2021

2022

Tax Expense


60

87

135

EBT


182

217

337

  Tax Rate


33.0%

40.1%

40.1%

1-Tax Rate


67.0%

59.9%

59.9%





Dry Bean Income Statement and Balance Sheet - 2020 - 2022




2020

2021

2022

Sales


1354

1751

2299

Cost of Sales


800

1128

1580

  Gross Margin

554

623

719







Operating Expenses

355

382

365


EBIT


199

241

354

Interest Expense

17

24

17


EBT


182

217

337

Income Tax


60

87

135

Net Income


122

130

202






Balance Sheet












2020

2021

2022

Cash


281

73

16

Accounts Receivable

34

180

274


Inventory


68

188

115

  Total Current Assets

383

441

405







Machinery and Equipment

129

156

420


Furniture and Fixtures

65

78

90


Accumulated Depreciation

-150

-181

-213


  Net Fixed Assets

44

53

297


Other Non-Current Assets

5

5

5


Total Assets


432

499

707






Accounts Payable

254

170

252


Current Portion of L-T Debt

50

76

83


Other Accruals

9

10

10


  Total Current Liabilities

313

256

345


Long-Term Debt

41

65

22


  Total Liabilities

354

321

367


Owner's Equity

50

50

50


Retained Earnings

28

128

290


  Total Equity


78

178

340

Liablitieis + Equity

432

499

707






댓글


© 2024 by Dr.Phil Greenwood,CPA, PhD. Proudly created with Wix.com

bottom of page